BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36801596)

  • 1. Nontarget screening based on molecular networking strategy to identify transformation products of citalopram and sertraline in wastewater.
    Wu G; Wang X; Zhang X; Ren H; Wang Y; Yu Q; Wei S; Geng J
    Water Res; 2023 Apr; 232():119509. PubMed ID: 36801596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive insight into the transformation pathways and products of fluoxetine and venlafaxine in wastewater based on molecular networking nontarget screening.
    Wu G; Wu T; Chen Y; He X; Liu P; Wang D; Geng J; Zhang XX
    Sci Total Environ; 2024 Jan; 907():167727. PubMed ID: 37864996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transformation mechanisms of the antidepressant citalopram in a moving bed biofilm reactor: Substrate-depended pathways, eco-toxicities and enantiomeric profiles.
    Liang C; Wei Z; Bester K
    Water Res; 2024 Mar; 252():121245. PubMed ID: 38335750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transformation products of citalopram: Identification, wastewater analysis and in silico toxicological assessment.
    Osawa RA; Carvalho AP; Monteiro OC; Oliveira MC; Florêncio MH
    Chemosphere; 2019 Feb; 217():858-868. PubMed ID: 30458421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revealing specific transformation pattern of sulfonamides during wastewater biological treatment processes by molecular networking nontarget screening.
    Wu G; Qian Y; Fan F; Zhang Z; Zhang Y; Yu Q; Zhang X; Ren H; Geng J; Liu H
    Water Res; 2023 May; 235():119895. PubMed ID: 36989798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Environmental risk assessment of three selective serotonin reuptake inhibitors in the aquatic environment: a case study including a cocktail scenario.
    Styrishave B; Halling-Sørensen B; Ingerslev F
    Environ Toxicol Chem; 2011 Jan; 30(1):254-61. PubMed ID: 20928917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of biotransformation products of citalopram formed in activated sludge.
    Beretsou VG; Psoma AK; Gago-Ferrero P; Aalizadeh R; Fenner K; Thomaidis NS
    Water Res; 2016 Oct; 103():205-214. PubMed ID: 27459150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicity Profile, Pharmacokinetic, and Drug-Drug Interaction Study of Citalopram and Sertraline Following Oral Delivery in Rat: An LC-MS/MS Method for the Simultaneous Determination in Plasma.
    Elgawish MS; Ali MA; Moustafa MA; Hafeez SM
    Chem Res Toxicol; 2020 Oct; 33(10):2584-2592. PubMed ID: 32957789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suspect and Nontarget Screening Reveal the Underestimated Risks of Antibiotic Transformation Products in Wastewater Treatment Plant Effluents.
    Hu J; Lyu Y; Chen H; Li S; Sun W
    Environ Sci Technol; 2023 Nov; 57(45):17439-17451. PubMed ID: 37930269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective serotonin reuptake inhibitors and β-blocker transformation products may not pose a significant risk of toxicity to aquatic organisms in wastewater effluent-dominated receiving waters.
    Brown AK; Challis JK; Wong CS; Hanson ML
    Integr Environ Assess Manag; 2015 Oct; 11(4):618-39. PubMed ID: 25820351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-target trend analysis for the identification of transformation products during ozonation experiments of citalopram and four of its biodegradation products.
    Nika MC; Aalizadeh R; Thomaidis NS
    J Hazard Mater; 2021 Oct; 419():126401. PubMed ID: 34182420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suspect and non-target screening of pesticides and pharmaceuticals transformation products in wastewater using QTOF-MS.
    Wang X; Yu N; Yang J; Jin L; Guo H; Shi W; Zhang X; Yang L; Yu H; Wei S
    Environ Int; 2020 Apr; 137():105599. PubMed ID: 32109725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiclass target analysis of contaminants of emerging concern including transformation products, soil bioavailability assessment and retrospective screening as tools to evaluate risks associated with reclaimed water reuse.
    Beretsou VG; Nika MC; Manoli K; Michael C; Sui Q; Lundy L; Revitt DM; Thomaidis NS; Fatta-Kassinos D
    Sci Total Environ; 2022 Dec; 852():158391. PubMed ID: 36049679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hexamethoxymethylmelamine - A precursor of persistent and mobile contaminants in municipal wastewater and the water cycle.
    Alhelou R; Seiwert B; Reemtsma T
    Water Res; 2019 Nov; 165():114973. PubMed ID: 31430651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degradation of duloxetine: Identification of transformation products by UHPLC-ESI(+)-HRMS/MS, in silico toxicity and wastewater analysis.
    Osawa RA; Carvalho AP; Monteiro OC; Oliveira MC; Florêncio MH
    J Environ Sci (China); 2019 Aug; 82():113-123. PubMed ID: 31133256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fate of citalopram during water treatment with O3, ClO2, UV and Fenton oxidation.
    Hörsing M; Kosjek T; Andersen HR; Heath E; Ledin A
    Chemosphere; 2012 Sep; 89(2):129-35. PubMed ID: 22704974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressants in wastewater treatment plants: Occurrence, transformation and acute toxicity evaluation.
    Wang W; Zhang J; Hu M; Liu X; Sun T; Zhang H
    Sci Total Environ; 2023 Dec; 903():166120. PubMed ID: 37579797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nontarget Discovery of Antimicrobial Transformation Products in Wastewater Based on Molecular Networks.
    Yu N; Deng Y; Wang X; Shi W; Zhou D; Pan B; Yu H; Wei S
    Environ Sci Technol; 2023 Jun; 57(22):8335-8346. PubMed ID: 37211672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prioritizing Unknown Transformation Products from Biologically-Treated Wastewater Using High-Resolution Mass Spectrometry, Multivariate Statistics, and Metabolic Logic.
    Schollée JE; Schymanski EL; Avak SE; Loos M; Hollender J
    Anal Chem; 2015 Dec; 87(24):12121-9. PubMed ID: 26575699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the aerobic biodegradation of glucocorticoids: Elucidation of the kinetics and transformation reactions.
    Weizel A; Schlüsener MP; Dierkes G; Wick A; Ternes TA
    Water Res; 2020 May; 174():115561. PubMed ID: 32087415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.